Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease
Robert Gilmore(The University of Queensland), Jakob Begun(Translational Research Institute), Ei Phyu Phyu Swe(The University of Queensland), Yoon‐Kyo An(Mater Hospital), Amirah Etchegaray(Mater Adult Hospital), Amrutha Murali(Mater Adult Hospital)
Cited by 8
Related Papers
Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis
|PLoS Genetics|2013|217
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
|Inflammatory Bowel Diseases|2019|94
Adhesion formation after previous caesarean section-a meta-analysis and systematic review
|BJOG An International Journal of Obstetrics & Gynaecology|2010|73
Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge
|JGH Open|2019|62
Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography
|Journal of Crohn s and Colitis|2020|62